1. Home
  2. EARN vs SRZN Comparison

EARN vs SRZN Comparison

Compare EARN & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EARN

Ellington Residential Mortgage REIT of Beneficial Interest

HOLD

Current Price

$5.30

Market Cap

200.3M

Sector

Real Estate

ML Signal

HOLD

Logo Surrozen Inc.

SRZN

Surrozen Inc.

N/A

Current Price

$22.50

Market Cap

164.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EARN
SRZN
Founded
2012
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medicinal Chemicals and Botanical Products
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
200.3M
164.3M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
EARN
SRZN
Price
$5.30
$22.50
Analyst Decision
Buy
Strong Buy
Analyst Count
2
1
Target Price
$5.88
$32.00
AVG Volume (30 Days)
399.2K
146.1K
Earning Date
03-11-2026
11-07-2025
Dividend Yield
17.58%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$35,893,000.00
$3,604,000.00
Revenue This Year
$8.43
N/A
Revenue Next Year
$17.28
N/A
P/E Ratio
N/A
N/A
Revenue Growth
43.30
N/A
52 Week Low
$4.33
$5.90
52 Week High
$6.70
$24.94

Technical Indicators

Market Signals
Indicator
EARN
SRZN
Relative Strength Index (RSI) 41.69 58.76
Support Level $5.55 $19.51
Resistance Level $5.72 $23.93
Average True Range (ATR) 0.11 2.15
MACD -0.02 0.25
Stochastic Oscillator 0.00 77.45

Price Performance

Historical Comparison
EARN
SRZN

About EARN Ellington Residential Mortgage REIT of Beneficial Interest

Ellington Credit Co is focused on corporate collateralized loan obligations (CLOs). It focuses on acquiring, investing in, and managing secondary CLO mezzanine debt and equity tranches. The company relies on risk management, including disciplined liquidity management and selective use of credit hedges, to preserve book value during times. The company primary investment objectives are to generate attractive current yields and risk-adjusted total returns for shareholders. It invest in multiple parts of the CLO capital structure, principally mezzanine debt and equity tranches. Rather than focusing only on short-term current yield, it select investments that it believe will provide a strong total return to drive a sustainable earnings stream over a long-term horizon.

About SRZN Surrozen Inc.

Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).

Share on Social Networks: